Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ribavirin aerosol in the elderly.

H P Liss1, J Bernstein

  • 1Department of Medicine, Wright State University School of Medicine, Dayton, OH.

Chest
|June 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same author

The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2024
Same author

A Retrospective Case Series of a Novel Spinal Cord Stimulator Trial Technique with Less Displacement and Migration of the Trial Leads.

Pain research & management·2019
Same author

Bilateral subtrochanteric femur insufficiency fractures after bariatric surgery: a case report.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Hepatic adenoma during pregnancy and anesthetic management.

International journal of obstetric anesthesia·2019
Same author

[Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention].

Revue medicale de Bruxelles·2018
Same journal

Wearable-derived activity and physiological changes following pleural intervention in malignant pleural effusion.

Chest·2026
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
See all related articles

Ribavirin aerosol is safe for elderly patients with COPD. Short-term use showed minimal respiratory changes, indicating good tolerability in this high-risk group.

Area of Science:

  • Pulmonology
  • Pharmacology
  • Geriatrics

Background:

  • Ribavirin aerosol is effective for viral infections in younger populations.
  • Its safety in elderly patients, especially those with COPD, remains unstudied.

Purpose of the Study:

  • To evaluate the safety and tolerability of ribavirin aerosol in elderly volunteers at high risk for influenza.
  • To assess the impact of ribavirin aerosol on pulmonary function in this demographic.

Main Methods:

  • Eight elderly volunteers (mean age 64, seven with COPD) received ribavirin aerosol for 2 or 6 hours daily for 96 hours.
  • Pulmonary function tests, including forced expiratory volume in one second (FEV1) and peak expiratory flow rate (PEFR), were monitored.

Main Results:

Related Experiment Videos

  • Ribavirin aerosol was generally well tolerated in all subjects.
  • A 2-hour treatment regimen showed small, transient decreases in FEV1, PEFR, and mid-expiratory flow, with stable symptoms.
  • A 6-hour treatment regimen resulted in no significant changes in pulmonary function.

Conclusions:

  • Ribavirin aerosol appears safe for elderly patients, including those with underlying COPD.
  • Short-term exposure (2-6 hours) did not lead to clinically significant adverse pulmonary events.
  • Further research may explore longer treatment durations or different patient populations.